Services
Fundraising Support for Life Sciences
Supporting biotech and life sciences companies in preparing, structuring and executing financing rounds — from seed to Series B and beyond.
Fundraising in life sciences is a demanding process: investors expect a clear scientific rationale, a compelling commercial story, defensible financials and a deal structure that aligns interests across stakeholders.
BDC supports founders and management teams at every step — from refining the equity story and preparing investor materials to identifying the right investors and supporting roadshow execution.
What We Do
- →Equity story and investor narrative
- →Pitch deck and investor materials preparation
- →Financial modelling and valuation support
- →Investor mapping and qualified outreach
- →Roadshow preparation and meeting support
- →Term sheet review and negotiation support
- →Seed, Series A, Series B and beyond — including pre-IPO rounds
Our Approach
We start from the investor's side of the table: we define what a specialist life sciences fund needs to see to commit, then build the equity story, the financial model and the materials backwards from that bar. The result is a round that stands up to the diligence biotech investors actually run.
Senior partners then prepare you for the room — message testing, objection handling and term-sheet strategy — and open doors through our network of venture funds, family offices and strategic investors across Europe, Israel, South Korea and the USA.
Typical situations we support
- →First institutional financing round
- →Bridge or extension financing
- →Series A or Series B with a new lead investor
- →Non-dilutive and grant strategy alongside an equity round
- →Pre-IPO positioning
Preparing a fundraising round?
Tell us about your stage and goals — we will help you build the right approach.